Insider Transactions in Q3 2023 at Travere Therapeutics, Inc. (TVTX)
Insider Transaction List (Q3 2023)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Sep 05
2023
|
Christopher R. Cline CHIEF FINANCIAL OFFICER |
SELL
Open market or private sale
|
Direct |
457
-0.9%
|
$6,398
$14.71 P/Share
|
|
Sep 05
2023
|
Eric M Dube CHIEF EXECUTIVE OFFICER |
SELL
Open market or private sale
|
Direct |
4,455
-1.8%
|
$62,370
$14.71 P/Share
|
|
Sep 05
2023
|
Elizabeth E Reed SVP, GC & CORPORATE SECRETARY |
SELL
Open market or private sale
|
Direct |
1,815
-3.03%
|
$25,410
$14.71 P/Share
|
|
Sep 05
2023
|
William E. Rote SENIOR VICE PRESIDENT, R&D |
SELL
Open market or private sale
|
Direct |
1,815
-2.88%
|
$25,410
$14.71 P/Share
|
|
Aug 31
2023
|
Eric M Dube CHIEF EXECUTIVE OFFICER |
BUY
Grant, award, or other acquisition
|
Direct |
9,900
+3.85%
|
-
|
|
Aug 31
2023
|
Elizabeth E Reed SVP, GC & CORPORATE SECRETARY |
BUY
Grant, award, or other acquisition
|
Direct |
3,300
+5.22%
|
-
|
|
Aug 31
2023
|
William E. Rote SENIOR VICE PRESIDENT, R&D |
BUY
Grant, award, or other acquisition
|
Direct |
3,300
+4.98%
|
-
|